Wall Street ends flat after choppy session

Stifel Cuts Price Target on Noble Energy (NBL) to $37 Following Israel Supreme Court Ruling

Stifel maintained a Buy rating on Noble Energy (NYSE: NBL), and cut the price target to $37.00 (from $40.00), following Supreme Court of Israel ruling that the government should provide stability assurances through a legal mechanism outside of the country's Natural Gas Regulatory Framework.

Analyst Michael... More

Rosenblatt Reiterates Buy on Pandora (P) as Tim Westergren Takes Over as CEO

Rosenblatt reiterated a Buy rating on Pandora (NYSE: P), with a price target of $15.00, following the company's announced management changes. The company announced that co-founder, Tim Westergren, is back in as CEO. Rosenblatt sees this move as very positive for the company on its fundamental... More

Piper Jaffray Remains Sidelined After Meeting with Pandora (P); Sees Changes as Positive

Piper Jaffray remains Neutral on Pandora (NYSE: P) after meeting with management to discuss announced management changes. The appointment of the founder Tim Westergren to CEO signals that the company is not up for sale, helping the company lock-in major music labels into new direct licensing deals.... More

Wedbush Cuts Price Target on GameStop (GME) to $36 Following 4Q Results

Wedbush maintained an Outperform rating on GameStop (NYSE: GME), and cut the price target to $36.00 (from $38.00), following the company's 4Q report and guidance. Sales totaled $3.53 billion, compared with the consensus estimate of $3.57 billion. Non-GAAP EPS was $2.40, compared with the consensus estimate of $2.25.

Analyst... More

Leerink Affirms ACADIA Pharma (ACAD) at 'Outperform'; Pimavanserin Briefing Docs More Crticial than Expected

Leerink affirms ACADIA Pharma (Nasdaq: ACAD) with an Outperform rating and $40 price target after the FDA Psychopharmacologic Drugs Advisory Committee released the pimavanserin briefing documents last Friday.

Analyst... More